Company Index
      
       









 
      
     
     
     
    BeiGene
      BeiGene
      
      NEWS
       
Hiring Ernst & Young in the U.S. may help but won’t work without a bilateral Sino-American accord on audit documents
Apr.8 2022 04:59 AM

With listing on STAR Market, loss-making cancer-drug developer would be the first Chinese biotech to trade shares on the mainland and in Hong Kong and New York
Nov.17 2021 05:11 AM

Eleven-year-old cancer-focused Chinese biotech turned its first profit this year after three of its drugs made China’s National Reimbursement Drug List
Jun.29 2021 06:18 AM

May.10 2021 18:28 PM

Dec.3 2020 18:17 PM

Beijing-based BeiGene will take over commercialization of three cancer medicines from American biopharmaceutical giant in China as part of deal, and work to commercialize 20 more
Nov.1 2019 18:25 PM

Nov.1 2019 10:16 AM

Top 15 listings by Chinese firms have raised $28.7 billion so far this year, led by China Tower this week
Aug.10 2018 17:18 PM

 After lackluster BeiGene IPO, analysts argue share prices will rise when more products hit market
Aug.8 2018 18:45 PM

Hong Kong IPO could raise nearly $1 billion, complementing drug developer’s current Nasdaq listing
Jul.30 2018 18:47 PM

 U.S. biopharmaceutical firm plans to hold 5.9% of cancer-drug developer to market new treatments in Europe and America
Jul.7 2017 18:44 PM
- Jun 16, 2025 02:54 PM
- Jun 16, 2025 02:53 PM
- Jun 16, 2025 02:52 PM
MOST POPULAR
  - 1Caixin Explains: What China’s New Five-Year Plan Says About the Economy
- 2Cover Story: U.S. and Chinese Chipmakers Tread Different Paths in AI Gold Rush
- 3Analysis: How Tech Self-Reliance Shapes China’s New Five-Year Plan
- 4Shenzhen’s Secondhand Home Sales Briefly Rebound in September After Easing of Purchase Restrictions
- 5China Promotes Military Graft Buster to Top Leadership Post
 
		

 Sign in with Google
               Sign in with Google
             Sign in with Facebook
              Sign in with Facebook
             Sign in with 财新
              Sign in with 财新